z-logo
open-access-imgOpen Access
FDA Approval of Nusinersen for Spinal Muscular Atrophy Makes 2016 the Year of Splice Modulating Oligonucleotides
Author(s) -
Annemieke AartsmaRus
Publication year - 2017
Publication title -
nucleic acid therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.255
H-Index - 67
eISSN - 2159-3345
pISSN - 2159-3337
DOI - 10.1089/nat.2017.0665
Subject(s) - spinal muscular atrophy , medicine , splice , bioinformatics , computational biology , physical medicine and rehabilitation , biology , anatomy , pathology , genetics , disease , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom